TWD 33.45
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.45 Billion TWD | -32.78% |
2022 | 2.16 Billion TWD | -4.75% |
2021 | 2.27 Billion TWD | -18.85% |
2020 | 2.8 Billion TWD | 69.49% |
2019 | 1.65 Billion TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 1.63 Billion TWD | 22.39% |
2024 Q1 | 1.35 Billion TWD | -7.37% |
2023 Q3 | 1.38 Billion TWD | -34.03% |
2023 Q2 | 2.09 Billion TWD | 4.52% |
2023 FY | 1.45 Billion TWD | -32.78% |
2023 Q1 | 2 Billion TWD | 0.0% |
2023 Q4 | 1.45 Billion TWD | 5.5% |
2022 Q4 | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | -1925.299% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | -1815.588% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | -341.431% |
TTY Biopharm Company Limited | 403.04 Million TWD | -261.918% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 33.785% |
Center Laboratories, Inc. | 4.42 Billion TWD | 67.065% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -386823.342% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | -350.586% |
InnoPharmax Inc. | 5.38 Million TWD | -26983.197% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | -1346.679% |
Excelsior Biopharma Inc. | 300.25 Million TWD | -385.829% |
DV Biomed Co., Ltd. | 315.74 Million TWD | -361.981% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -11022.387% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -18915.787% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | -191.918% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -1056929.71% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -2502.175% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -3400.77% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -2121.767% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |